These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 16237574)

  • 21. Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
    Ikeda N; Hayasaka S; Kadoi C; Nagaki Y
    Ophthalmologica; 1999; 213(3):197-9. PubMed ID: 10202295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute lymphoblastic leukemia manifesting as acute Vogt-Koyanagi-Harada disease.
    Yang HK; Yu HG
    Korean J Ophthalmol; 2009 Dec; 23(4):325-8. PubMed ID: 20046700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging.
    Fukutsu K; Namba K; Iwata D; Mizuuchi K; Kase S; Suzuki K; Shimizu H; Shibata Y; Yamawaki F; Onozawa M; Ishida S
    BMC Ophthalmol; 2020 Mar; 20(1):94. PubMed ID: 32156266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual case of vitiligo reversal in Vogt-Koyanagi-Harada syndrome.
    Subudhi P; Khan Z; Subudhi BNR; Sitaram S
    Indian J Ophthalmol; 2017 Sep; 65(9):867-868. PubMed ID: 28905833
    [No Abstract]   [Full Text] [Related]  

  • 25. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
    Parc C; Guenoun JM; Dhote R; Brézin A
    Ocul Immunol Inflamm; 2005; 13(2-3):225-7. PubMed ID: 16019683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological and immunohistochemistry correlation in a case of Vogt-Koyanagi-Harada disease.
    Das D; Boddepalli A; Biswas J
    Indian J Ophthalmol; 2019 Jul; 67(7):1217-1219. PubMed ID: 31238472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case of Vogt-Koyanagi-Harada Syndrome Mimicking Optic Neuritis.
    Amir MM; Masood A; Khan Z
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):325-326. PubMed ID: 29615180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
    Gruich MJ; Evans OB; Storey JM; Bradley ST; Chen CJ
    Pediatr Neurol; 1995 Jul; 13(1):50-1. PubMed ID: 7575849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early manifestation of vogt-koyanagi-harada disease as unilateral posterior scleritis.
    Kouda N; Sasaki H; Harada S; Yamada Y; Takahashi N; Sasaki K
    Jpn J Ophthalmol; 2002; 46(5):590-3. PubMed ID: 12457922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case report: co-occurrence of probable Vogt-Koyanagi-Harada disease and diabetic retinopathy.
    Li H; Li Z; Mao A; Dong P; Wang W
    BMC Ophthalmol; 2024 Apr; 24(1):148. PubMed ID: 38566041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of Vogt-Koyanagi-Harada syndrome.
    Hettler DL; Levinson JB
    J Am Optom Assoc; 1992 Feb; 63(2):90-4. PubMed ID: 1583270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
    Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vogt-Koyanagi-Harada disease in 3-year-old boy.
    Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
    Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of ocular complications of Vogt-Koyanagi-Harada syndrome.
    Perente I; Utine CA; Cakir H; Kaya V; Tutkun IT; Yilmaz OF
    Int Ophthalmol; 2009 Feb; 29(1):33-7. PubMed ID: 17952373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
    Yamaguchi Y; Otani T; Kishi S
    Am J Ophthalmol; 2007 Aug; 144(2):260-5. PubMed ID: 17533104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vogt-Koyanagi-Harada disease].
    Kjeka O; Krohn J
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iris atrophy, serous detachment of the ciliary body, and ocular hypotony in chronic phase of Vogt-Koyanagi-Harada disease.
    Saari JM; Nummelin K
    Eur J Ophthalmol; 2005; 15(2):277-83. PubMed ID: 15812774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for subretinal fibrosis in patients with Vogt Koyanagi Harada syndrome.
    Golzarri MF; Cheja-Kalb R; Concha-Del-Río LE; Gonzalez-Salinas R; Arellanes-García L
    Ocul Immunol Inflamm; 2022 Feb; 30(2):265-269. PubMed ID: 33021860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suprachoroidal triamcinolone acetonide injection: a novel therapy for serous retinal detachment due to Vogt-Koyanagi Harada disease.
    Tabl AA; Elsayed MA; Tabl MA
    Eur J Ophthalmol; 2022 Nov; 32(6):3482-3488. PubMed ID: 35266801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.